Subnormal Growth Velocity and Related Factors During GnRH Analog Therapy for Idiopathic Central Precocious Puberty
Open Access
- 31 July 2018
- journal article
- research article
- Published by Galenos Yayinevi in Journal of Clinical Research in Pediatric Endocrinology
- Vol. 10 (3) , 239-246
Abstract
Data concerning subnormal growth velocity (GV) and factors that influence this during gonadotropin-releasing hormone analog (GnRHa) therapy for idiopathic central precocious puberty (ICPP) are scarce. We investigated the incidence of subnormal GV and associated factors in patients receiving GnRHa therapy for ICPP. In this retrospective cohort study, the records of 50 girls who had been diagnosed with ICPP and started on GnRHa treatment before the age of eight years were investigated. Subnormal GV frequency, related factors during GnRHa therapy and the effect on final height were examined. During the treatment, a significant decrease in the annual GV and GV standard deviation score (SDS) of the patients was observed. In 16 (32%) patients GV never declined below -1 SDS, while a decline was noted once and twice in 19 (38%) and 15 (30%) patients respectively. The median age of detection of subnormal GV was 9.9 (4.9-10.9) years. Patients with pubic hair at diagnosis were found to have an increased risk of subnormal GV (p=0.016). There was a significant negative correlation between diagnostic basal luteinizing hormone (LH) level and the first and second year GV SDS (p=0.012 and 0.017 respectively). A significant negative correlation between bone age at diagnosis and 3rd year GV SDS, and 4th year GV SDS (p=0.002 and p=0.038) was also observed. LH suppression significantly increased during treatment (p=0.001). In girls with ICPP the risk of subnormal GV appears highest at the 3rd year of GnRHa treatment, particularly in those patients with, at the time of diagnosis, pubic hair in conjunction with high baseline and peak LH and advanced BA and excessive LH suppression on follow-up.Keywords
This publication has 21 references indexed in Scilit:
- Growth references for Turkish children aged 6 to 18 yearsActa Paediatrica, 2006
- Effects of estrogen on growth plate senescence and epiphyseal fusionProceedings of the National Academy of Sciences, 2001
- Quantitative histomorphometric analysis of the human growth plate from birth to adolescenceBone, 2000
- Use of an Ultrasensitive Recombinant Cell Bioassay to Determine Estrogen Levels in Girls with Precocious Puberty Treated with a Luteinizing Hormone-Releasing Hormone AgonistThe Journal of Clinical Endocrinology & Metabolism, 1998
- Combined treatment with gonadotropin-releasing hormone analog and growth hormone in central precocious puberty.The Journal of Clinical Endocrinology & Metabolism, 1996
- Growth velocity and serum aminoterminal propeptide of type III procollagen in precocious puberty during gonadotropin‐releasing hormone analogue treatmentActa Paediatrica, 1993
- Suppression of the Pituitary-Gonadal Axis in Children with Central Precocious Puberty: Effects on Growth, Growth Hormone, Insulin-Like Growth Factor-I, and Prolactin Secretion*The Journal of Clinical Endocrinology & Metabolism, 1991
- Low Growth Hormone Levels Are Related to Increased Body Mass Index and Do not Reflect Impaired Growth in Luteinizing Hormone-Releasing Hormone Agonist-Treated Children with Precocious PubertyThe Journal of Clinical Endocrinology & Metabolism, 1991
- Long‐Term Results with a Slow‐Release Gonadotrophin‐Releasing Hormone Agonist in Central Precocious PubertyActa Paediatrica, 1991
- The Pubertal Growth Spurt in Eight Patients with True Precocious Puberty and Growth Hormone Deficiency: Evidence for a Direct Role of Sex Steroids*The Journal of Clinical Endocrinology & Metabolism, 1990